Skip to main content
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
58.08
-4.80 (-7.63%)
At close: Apr 17, 2025, 4:00 PM
58.80
+0.72 (1.24%)
After-hours: Apr 17, 2025, 7:59 PM EDT

Novo Nordisk Revenue by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes
28.71B 27.52B 26.78B 25.35B 24.10B 22.39B 21.49B 20.46B
Diabetes Growth
19.11% 22.93% 24.59% 23.92% 24.31% 21.21% 23.23% 23.53%
Obesity
9.05B 7.64B 6.73B 6.23B 5.78B 4.99B 3.89B 2.96B
Obesity Growth
56.48% 53.16% 73.14% 110.41% 146.87% 159.42% 134.98% 107.82%
Rare Disease
2.59B 2.43B 2.34B 2.36B 2.38B 2.42B 2.59B 2.74B
Rare Disease Growth
8.60% 0.34% -9.75% -14.09% -16.45% -14.49% -5.81% 0.85%

Operating Income by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes and Obesity Care
17.74B 16.35B 15.42B 14.82B 13.84B 12.58B 11.39B 10.45B
Diabetes and Obesity Care Growth
28.20% 29.95% 35.29% 41.90% 47.82% 45.45% 43.47% 40.66%
Rare Disease
86.14M 91.84M 70.02M 379.99M 410.00M 322.19M 577.00M 762.75M
Rare Disease Growth
-78.99% -71.50% -87.86% -50.18% -60.20% -74.47% -55.13% -41.36%

Revenue by Geography
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
North America
24.75B 22.98B 21.93B 20.37B 18.98B 16.77B 15.20B 13.95B
North America Growth
30.41% 37.09% 44.35% 46.01% 49.97% 42.69% 40.05% 39.09%
International
15.59B 14.61B 13.91B 13.56B 13.29B 13.04B 12.78B 12.21B
International Growth
17.36% 12.08% 8.89% 11.10% 11.40% 13.54% 16.16% 14.38%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.